Our aim was to mutate and knock out TET2 [a commonly mutated gene in AML and myeloid malignancies (28)], and hypermethylate p15/p14 in two stages, to simulate two sequential aberrant hits. This evidence concerns the gene TET2 and acute myeloid leukemia.